Theodore S. Jennaro

机构：AbbVie (United States) · ORCID：0000-0002-2496-6374

发表论文 20 篇 · 总被引 200 次 · h-index 9

代表论文

• Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy (2020 · Breast Cancer Research and Treatment · 被引 37)
• Charge Segregation and Low Hydrophobicity Are Key Features of Ribosomal Proteins from Different Organisms (2014 · Journal of Biological Chemistry · 被引 31)
• Pharmacometabolomics identifies candidate predictor metabolites of an L‐carnitine treatment mortality benefit in septic shock (2021 · Clinical and Translational Science · 被引 18)
• Using l ‐Carnitine as a Pharmacologic Probe of the Interpatient and Metabolic Variability of Sepsis (2020 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 被引 17)
• Sustained Perturbation of Metabolism and Metabolic Subphenotypes Are Associated With Mortality and Protein Markers of the Host Response (2023 · Critical Care Explorations · 被引 15)
• Telisotuzumab adizutecan (ABBV-400; Temab-A), a c-Met protein–targeting antibody-drug conjugate (ADC), in patients (pts) with advanced EGFR -mutated (MT) non-squamous (NSQ) non-small cell lung cancer (NSCLC): Results from a phase 1 study. (2025 · Journal of Clinical Oncology · 被引 14)